Cardiovascular risk and dyslipidemia among persons living with HIV: a review

P Maggi, A Di Biagio, S Rusconi, S Cicalini… - BMC infectious …, 2017 - Springer
Background Aim of this review is to focus the attention on people living with HIV infection at
risk of developing a cardiovascular event. What is or what would be the most suitable …

Fenofibrate: a review of its use in dyslipidaemia

K McKeage, GM Keating - Drugs, 2011 - Springer
Fenofibrate is a fibric acid derivative indicated for the treatment of severe
hypertriglyceridaemia and mixed dyslipidaemia in patients who have not responded to …

Antithyroid drug‐related hepatotoxicity in hyperthyroidism patients: a population‐based cohort study

MT Wang, WJ Lee, TY Huang, CL Chu… - British journal of …, 2014 - Wiley Online Library
Aims The evidence of hepatotoxicity of antithyroid drugs (ATDs) is limited to case reports or
spontaneous reporting. This study aimed to quantify the incidence and comparative risks of …

Methods of assessing renal function

G Filler, A Yasin, M Medeiros - Pediatric nephrology, 2014 - Springer
Accurate assessment of renal function is critical for appropriate drug dosing of renally
excreted compounds. Glomerular filtration rate (GFR) is considered the best marker of …

A narrative review of statin-induced rhabdomyolysis: molecular mechanism, risk factors, and management

N Safitri, MF Alaina, DAE Pitaloka… - Drug, healthcare and …, 2021 - Taylor & Francis
Although statins are effective for treating hypercholesterolemia, they can have various side
effects, including rhabdomyolysis, a potentially fatal condition. This review evaluated the …

Fenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus

GM Keating - American Journal of Cardiovascular Drugs, 2011 - Springer
Fenofibrate is a fibric acid derivative with lipid-modifying effects that are mediated by the
activation of peroxisome proliferator-activated receptor-α. Fenofibrate also has a number of …

Medical management of diabetic retinopathy: fenofibrate and ACCORD Eye studies

AD Wright, PM Dodson - Eye, 2011 - nature.com
The approach of all ophthalmologists, diabetologists and general practitioners seeing
patients with diabetic retinopathy should be that good control of blood glucose, blood …

Cardiovascular implications of HIV-induced dyslipidemia

C Giannarelli, RS Klein, JJ Badimon - Atherosclerosis, 2011 - Elsevier
Cardiovascular disease (CVD) is currently the second most frequent cause of death (after
cancer) among HIV-positive subjects. The clinical use of highly active antiretroviral therapy …

Peroxisome proliferator-activated receptor α as a novel therapeutic target for schizophrenia

Y Wada, M Maekawa, T Ohnishi, S Balan… - …, 2020 - thelancet.com
Background The pathophysiology of schizophrenia, a major psychiatric disorder, remains
elusive. In this study, the role of peroxisome proliferator-activated receptor (PPAR)/retinoid X …

Elevated serum non-HDL (high-density lipoprotein) cholesterol and triglyceride levels as residual risks for myocardial infarction recurrence under statin treatment

K Suzuki, T Oikawa, K Nochioka, M Miura… - … and Vascular Biology, 2019 - Am Heart Assoc
Objective—Secondary prevention for recurrent myocardial infarction (MI) is one of the most
important therapeutic goals in patients with old MI (OMI). Although statins are widely used for …